Apoptotic signaling in multiple myeloma: Therapeutic implicationsCHAUHAN, Dharminder; HIDESHIMA, Teru; ANDERSON, Kenneth C et al.International journal of hematology. 2003, Vol 78, Num 2, pp 114-120, issn 0925-5710, 7 p.Article

Proteasome inhibition in multiple myeloma: Therapeutic implicationCHAUHAN, Dharminder; HIDESHIMA, Teru; ANDERSON, Kenneth C et al.Annual review of pharmacology and toxicology. 2005, Vol 45, pp 465-476, issn 0362-1642, 12 p.Article

Intracellular protein degradation and its therapeutic implicationsHIDESHIMA, Teru; BRADNER, James E; CHAUHAN, Dharminder et al.Clinical cancer research. 2005, Vol 11, Num 24, pp 8530-8533, issn 1078-0432, 4 p., 1Article

Growth inhibition and apoptosis of myeloma cells by the CDK inhibitor flavopiridolSEMENOV, Igor; AKYUZ, Canan; ROGINSKAYA, Vera et al.Leukemia research. 2002, Vol 26, Num 3, pp 271-280, issn 0145-2126Article

Biologic sequelae of c-Jun NH₂-terminal kinase (JNK) activation in multiple myeloma cell linesHIDESHIMA, Teru; HAYASHI, Toshiaki; CHAUHAN, Dharminder et al.Oncogene (Basingstoke). 2003, Vol 22, Num 54, pp 8797-8801, issn 0950-9232, 5 p.Article

Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cellsCHAUHAN, Dharminder; BANDI, Madhavi; SINGH, Ajita V et al.British journal of haematology. 2011, Vol 155, Num 5, pp 588-598, issn 0007-1048, 11 p.Article

The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implicationsPODAR, Klaus; ZIMMERHACKL, Alexander; SATTTER, Martin et al.British journal of haematology. 2011, Vol 155, Num 4, pp 438-448, issn 0007-1048, 11 p.Article

In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465NEGRI, Joseph M; MCMILLIN, Douglas W; POLLARD, John et al.British journal of haematology. 2009, Vol 147, Num 5, pp 672-676, issn 0007-1048, 5 p.Article

Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3NELSON, Erik A; WALKER, Sarah R; KEPICH, Alicia et al.Blood. 2008, Vol 112, Num 13, pp 5095-5102, issn 0006-4971, 8 p.Article

Nuclear factor-κB p65 mediates tumor necrosis factor α-induced nuclear translocation of telomerase reverse transcriptase proteinAKIYAMA, Masaharu; HIDESHIMA, Teru; HAYASHI, Toshiaki et al.Cancer research (Baltimore). 2003, Vol 63, Num 1, pp 18-21, issn 0008-5472, 4 p.Article

Antitumor activity of lysophosphatidic acid acyltransferase-β inhibitors, a novel class of agents, in multiple myelomaHIDESHIMA, Teru; CHAUHAN, Dharminder; MUNSHI, Nikhil et al.Cancer research (Baltimore). 2003, Vol 63, Num 23, pp 8428-8436, issn 0008-5472, 9 p.Article

NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myelomaCATLEY, Laurence; WEISBERG, Ellen; MUNSHI, Nikhil C et al.Blood. 2003, Vol 102, Num 7, pp 2615-2622, issn 0006-4971, 8 p.Article

Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myelomaHIDESHIMA, Teru; CHAUHAN, Dharminder; HAYASHI, Toshiaki et al.Oncogene (Basingstoke). 2003, Vol 22, Num 52, pp 8386-8393, issn 0950-9232, 8 p.Article

Identification of genes regulated by Dexamethasone in multiple myeloma cells using oligonucleotide arraysCHAUHAN, Dharminder; AUCLAIR, Daniel; LAN BO CHEN et al.Oncogene (Basingstoke). 2002, Vol 21, Num 9, pp 1346-1358, issn 0950-9232Article

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myelomaRICHARDSON, Paul G; SCHLOSSMAN, Robert L; MCKENNEY, Mary et al.Blood. 2002, Vol 100, Num 9, pp 3063-3067, issn 0006-4971, 5 p.Article

Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myelomaTREON, Steven P; MAIMONIS, Peter; HILGERS, Jo et al.Blood. 2000, Vol 96, Num 9, pp 3147-3153, issn 0006-4971Article

A novel vascular disrupting agent plinabulin triggers JNK-mediated apoptosis and inhibits angiogenesis in multiple myeloma cellsSINGH, Ajita V; BANDI, Madhavi; RAJE, Noopur et al.Blood. 2011, Vol 117, Num 21, pp 5692-5700, issn 0006-4971, 9 p.Article

Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myelomaCHAUHAN, Dharminder; SINGH, Ajita V; CICCARELLI, Bryan et al.Blood. 2010, Vol 115, Num 4, pp 834-845, issn 0006-4971, 12 p.Article

The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cellsHIDESHIMA, Teru; RICHARDSON, Paul; CHAUHAN, Dharminder et al.Cancer research (Baltimore). 2001, Vol 61, Num 7, pp 3071-3076, issn 0008-5472Article

Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myelomaCHAUHAN, Dharminder; SINGH, Ajita; BRAHMANDAM, Mohan et al.Blood. 2008, Vol 111, Num 3, pp 1654-1664, issn 0006-4971, 11 p.Article

In Vitro and In Vivo Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma CellsCHAUHAN, Dharminder; RAY, Arghya; VIKTORSSON, Kristina et al.Clinical cancer research (Print). 2013, Vol 19, Num 11, pp 3019-3031, issn 1078-0432, 13 p.Article

Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine modelSINGH, Ajita V; PALLADINO, Michael A; LLOYD, George Kenneth et al.British journal of haematology. 2010, Vol 149, Num 4, pp 550-559, issn 0007-1048, 10 p.Article

Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132CRAWFORD, Lisa J. A; WALKER, Brian; OVAA, Huib et al.Cancer research (Baltimore). 2006, Vol 66, Num 12, pp 6379-6386, issn 0008-5472, 8 p.Article

Novel therapies targeting the myeloma cell and its bone marrow microenvironmentHIDESHIMA, Teru; CHAUHAN, Dharminder; PODAR, Klaus et al.Seminars in oncology. 2001, Vol 28, Num 6, pp 607-612, issn 0093-7754Article

Antimyeloma Activity of a Multitargeted Kinase Inhibitor, AT9283, via Potent Aurora Kinase and STAT3 Inhibition Either Alone or in Combination with LenalidomideSANTO, Loredana; HIDESHIMA, Teru; UNITT, Christine et al.Clinical cancer research (Print). 2011, Vol 17, Num 10, pp 3259-3271, issn 1078-0432, 13 p.Article